Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bioalpha Holdings BhdXKLS:0179 Piotroski F-Score is 2 as of Jul. 14, 2026, which is 50% below its 10-year median of 4.00. The stock has 6 warning signs investors should review. Among 1,914 Consumer Packaged Goods companies, Bioalpha Holdings Bhd ranks worse than 94.72% on this metric.
Warning Sign:
Piotroski F-Score of 2 is low, which usually implies poor business operation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Bioalpha Holdings Bhd has an F-score of 2. It is a bad or low score, which usually implies poor business operation.
The historical rank and industry rank for Bioalpha Holdings Bhd's Piotroski F-Score or its related term are showing as below:
XKLS:0179'
s Piotroski F-Score Range Over the Past 10 Years
Min: 2 Med: 4 Max: 7
Current: 2
During the past 13 years, the highest Piotroski F-Score of Bioalpha Holdings Bhd was 7. The lowest was 2. And the median was 4.
Bioalpha Holdings Bhd (XKLS:0179) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Bioalpha Holdings Bhd Piotroski F-Score Related Terms
Bioalpha Holdings Bhd Piotroski F-Score Historical Data
* Premium members only.
The historical data trend for Bioalpha Holdings Bhd's Piotroski F-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0179 vs KHC, GIS: Piotroski F-Score Comparison
For the Packaged Foods subindustry, Bioalpha Holdings Bhd's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioalpha Holdings Bhd Piotroski F-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Bioalpha Holdings Bhd's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Bioalpha Holdings Bhd's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Bioalpha Holdings Bhd's current Net Income (TTM) was -27.76.
==> Negative ==> Score 0.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Bioalpha Holdings Bhd's current Cash Flow from Operations (TTM) was -3.82.
==> Negative ==> Score 0.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
Bioalpha Holdings Bhd's return on assets of this year was -0.25791166. Bioalpha Holdings Bhd's return on assets of last year was -0.22719148.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Bioalpha Holdings Bhd's gearing of this year was 0.03424863. Bioalpha Holdings Bhd's gearing of last year was 0.02892075.
==> Last year is lower than this year ==> Score 0.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Bioalpha Holdings Bhd's current ratio of this year was 3.47089792. Bioalpha Holdings Bhd's current ratio of last year was 4.52264808.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Bioalpha Holdings Bhd's number of shares in issue this year was 1680.193. Bioalpha Holdings Bhd's number of shares in issue last year was 1546.9.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Bioalpha Holdings Bhd's gross margin of this year was 0.00421533. Bioalpha Holdings Bhd's gross margin of last year was -0.02370873.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Bioalpha Holdings Bhd's asset turnover of this year was 0.10580157. Bioalpha Holdings Bhd's asset turnover of last year was 0.42612565.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
0
+
0
+
0
+
1
+
0
+
0
+
0
+
1
+
0
=
2
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Bioalpha Holdings Bhd has an F-score of 2. It is a bad or low score, which usually implies poor business operation.
Bioalpha Holdings Bhd (XKLS:0179) has a Piotroski F-Score of 2 as of Jul. 14, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Bioalpha Holdings Bhd and its competitors. This is 50% below median its historical median of 4.00. Over the past decade, Bioalpha Holdings Bhd's Piotroski F-Score has ranged from 2.00 to 7.00. According to the industry distribution chart, Bioalpha Holdings Bhd ranks #1813 out of 1914 companies in the Consumer Packaged Goods industry, placing it in the top 94.7%.
Is Bioalpha Holdings Bhd's Piotroski F-Score too high?
Bioalpha Holdings Bhd's current Piotroski F-Score of 2 is 50% below median its 10-year median of 4.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 7.00. The Consumer Packaged Goods industry median Piotroski F-Score is 5.00. Bioalpha Holdings Bhd's value of 2 is 60% below this industry median. Based on the distribution chart, Bioalpha Holdings Bhd ranks #1813 out of 1914 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does Bioalpha Holdings Bhd's Piotroski F-Score compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Bioalpha Holdings Bhd ranks #1813 out of 1914 companies for Piotroski F-Score. This places Bioalpha Holdings Bhd in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Bioalpha Holdings Bhd's value of 2 is 60% below this benchmark. Historically, Bioalpha Holdings Bhd's own Piotroski F-Score has ranged from 2.00 to 7.00 over the past decade. While the company's 10-year median is 4.00 vs. the industry median of 5.00, Bioalpha Holdings Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Consumer Packaged Goods company?
The median Piotroski F-Score among Consumer Packaged Goods companies is 5.00, based on 1,914 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioalpha Holdings Bhd's current Piotroski F-Score of 2 is 60% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Bioalpha Holdings Bhd and its competitors. For the Consumer Packaged Goods industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioalpha Holdings Bhd's current Piotroski F-Score is 2, which is 50% below median its own 10-year median of 4.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioalpha Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Bioalpha Holdings Bhd (XKLS:0179) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.01, compared to a current price of RM0.02 — trading 100% above its estimated fair value. The current Piotroski F-Score is 2, which is 50% below median its 10-year median of 4.00 and 60% below the Consumer Packaged Goods industry median of 5.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Bioalpha Holdings Bhd (XKLS:0179), the current Piotroski F-Score is 2 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bioalpha Holdings Bhd is a nutraceutical and health supplement group in Malaysia, operates a multi-faceted value chain that includes agricultural development, research and development (R&D), and the manufacturing of functional food and supplement products on an Original Design Manufacturer (ODM) basis. The business operates in segments that include Trading, Manufacturing, Retail pharmacy, and Others. It generates maximum revenue from Manufacturing segment, which involves Research, development, manufacture, importer, exporter, distribution and trader of nutritional and health care products. Geographically, the company derives majority revenue from Malaysia, while it also has its presence in China and Others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0179 has been successfully added to your 
